Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 832-837 , August 2000

Risk of myocardial infarction after oophorectomy and hysterectomy

  • Margareta Falkeborn

      Affiliations

    • Department of Public Health and Caring Sciences/Geriatrics, University of Uppsala, Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Department of Geriatrics, P.O. Box 609, S-751 25 Uppsala, Sweden. Tel: +46-18 17 79 68; fax: +46-18 17 79 76
    • ,
  • Catherine Schairer

      Affiliations

    • Environmental Epidemiology Branch, National Cancer Institute, Rockville, MD, USA
    • ,
  • Tord Naessén

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital, Uppsala, Sweden
    • ,
  • Ingemar Persson

      Affiliations

    • Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden

Received 6 April 1998 ,Accepted 5 January 2000.

References 

  1. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham study. Ann Int Med. 1978;89:157–161
  2. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 1981;139:47–51
  3. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105–1110
  4. Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol. 1992;136:408–416
  5. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347:714–718
  6. Lapidus L, Bengtsson C, Lindquist O. Menopausal age and the risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Obstet Gynecol Scand. 1985;suppl)130:37–41
  7. La Veechia C, Decarli A, Franceschi S, Gentile A, Negri E, Parazzini F. Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol. 1987;157:1108–1112
  8. Punnonen R, Ikäläinen M, Seppälä E. Premenopausal hysterectomy and risk of cardiovascular disease. Lancet. 1987;i:1139
  9. Centerwall BS. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol. 1981;139:58–61
  10. Witteman JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ. 1989;298:642–644
  11. Luoto R, Kaprio J, Reunanen A, Rutanen EM. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol. 1995;85:515–522
  12. Rein MS, Barbieri RL, Friedman AJ. Progesterone (a critical role in the pathogenesis of uterine myomas). Am J Obstet Gynecol. 1995;172:14–18
  13. Naessén T, Parker R, Persson I, Zack M, Adami H-O. Time trends in incidence rates of first hip fracture in the Uppsala health care region, Sweden, 1965–1983. Am J Epidemiol. 1989;130:289–299
  14. Wacholder S, Boivin JF. External comparisons with the case-cohort design. Am J Epidemiol. 1987;126:1198–1209
  15. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 3rd edition. Baltimore, MD, USA: Williams & Wilkins; 1983;
  16. Harrison-Woolrych BM, Robinson R. Fibroid growth in response to high-dose progestogen. Fertil Steril. 1995;64:191–192
  17. Lobo RA. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol. 1990;75(suppl):18S–25S
  18. Parazzini F, Negri E, La Vecchia C, Rabaiotti M, Luchini L, Villa A, et al. Uterine myomas and smoking. Results from an Italian study. J Reprod Med. 1996;41:316–320
  19. Samadi AR, Lee NC, Flanders WD, Boring JR, Parris EB. Risk factors for self-reported uterine fibroids (a case-control study). Am J Public Health. 1996;86:858–862
  20. Ogawa A, Kanda T, Sugihara S, Masumo H, Kobayashi I. Risk factors for myocardial infarction in cancer patients. J Med. 1995;26:221–233
  21. Johansson S, Vedin A, Wilhelmsson C. Myocardial infarction in women. Epidemiol Rev. 1983;5:67–95
  22. Falkeborn M, Persson I, Adami H-O, Bergström R, Eaker E, Lithell H, et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol. 1992;99:821–828
  23. Bush TL, Barrett-Connor E, Cowan LD, et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women (results from the Lipid Research Clinics program follow-up study). Circulation. 1987;75:1102–1109
  24. Hagstad A, Janson PO. The epidemiology of climacteric symptoms. Acta Obstet Gynecol Scand. 1986;suppl 134:59–65
  25. Oldenhave A, Jaszmann LJB, Everaerd WTAM, Haspels AA. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol. 1993;168:765–771

PII: S0895-4356(00)00187-6

Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 832-837 , August 2000

Article Tools